In vitro, JAKi treatment synergized with hyperinsulinemia to suppress differentiation of CD4+ cells by inhibiting transcription factors essential for lineage maturation, thereby facilitating senescent effector cell elimination. This evidence concerns the gene CD4 and Hyperinsulinemia.